Ironwood Pharmaceuticals | IRWD - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Almirall EUR 19.58M 7M 2025-12
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amarin USD -1.22M 6.51M 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
Astellas Pharma JPY 141.83B 98.31B 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Charles River Laboratories USD -1.48M 13.36M 2026-06
Coherus Biosciences USD -37.64M 2.11M 2025-12
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Incyte USD 585.6M 282.27M 2026-06
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
MacroGenics USD -36.77M 22.62M 2026-03
Moderna USD -1.34B 517M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
Pacira USD 4.65M 1.74M 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY 113.2B 137.52B 2026-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12